Skip to content
Guardian Primary Care
Home›Resources›Article
Women's Health

HRT & Menopause: What Women Should Know

Preston Holifield, DNP, APRN, FNP-C•First published November 17, 2026•11 min read
A woman stretching on a yoga mat in an open field

Hot flashes. Night sweats. Poor sleep. Vaginal dryness. Brain fog. Mood changes.

For some women, the menopause transition is a minor inconvenience. For others, it can feel like someone quietly changed the settings on their body overnight.

That is usually when the question comes up:

“Should I be taking hormones?”

Hormone replacement therapy (HRT), also called menopausal hormone therapy (MHT), can be extremely effective for the right patient. But it is not something every woman needs, nor is it appropriate for everyone.

The goal should not be to be pro-HRT or anti-HRT. The goal is to understand your symptoms, your health history, your individual risks, and the available options, and then make a thoughtful decision together.

First: What Happens During Menopause?

Menopause is a normal biological transition. As ovarian function changes, levels of hormones such as estrogen fluctuate and eventually decline.

During perimenopause, those hormone levels can fluctuate considerably. This is one reason symptoms can seem unpredictable: one month may feel relatively normal, while the next is very different.

Common symptoms can include:

  • Hot flashes and night sweats
  • Sleep disruption
  • Vaginal or vulvar dryness
  • Pain with intercourse
  • Changes in urinary symptoms
  • Mood changes
  • Difficulty concentrating or “brain fog”
  • Changes in sexual function

Importantly, not every symptom that develops in your 40s or 50s is automatically caused by menopause. Thyroid disease, anemia, sleep disorders, medication effects, depression, anxiety, and other medical conditions can sometimes produce similar symptoms.

That is why good menopause care starts with a conversation, not automatically with a prescription.

So, What Exactly Is HRT?

The primary hormone used to treat menopause symptoms is estrogen.

Estrogen can be delivered several ways, including:

  • A skin patch
  • Gel or spray
  • Oral medication
  • Vaginal creams, tablets, inserts, or rings for primarily vaginal/urinary symptoms

If you still have a uterus, systemic estrogen generally needs to be paired with a progestogen to protect the uterine lining. Taking systemic estrogen without adequate endometrial protection can increase the risk of endometrial cancer.

If you have had your uterus removed, estrogen can often be used without a progestogen.

This distinction matters. “HRT” is not one medication. The hormone, dose, route, and whether progesterone/progestin is needed all affect the treatment decision.

What Does HRT Actually Treat Well?

This is where the evidence is strongest.

🔥 Hot flashes and night sweats

Systemic hormone therapy remains the most effective treatment available for menopausal vasomotor symptoms, meaning hot flashes and night sweats.

For a woman waking up drenched several times every night, that improvement can have a ripple effect: better sleep, better daytime function, and often a better overall quality of life.

🌙 Sleep

Hormone therapy may improve sleep when menopause-related hot flashes and night sweats are repeatedly waking someone up.

But insomnia has many causes. If hot flashes are not the reason you are awake, simply increasing hormones is not necessarily the answer.

❤️ Vaginal and urinary symptoms

Declining estrogen can affect vaginal and vulvar tissues and the urinary tract. This is called genitourinary syndrome of menopause (GSM).

Symptoms can include dryness, irritation, burning, painful intercourse, and some urinary symptoms.

When these are the main concern, women often do not need systemic HRT at all.

Low-dose vaginal estrogen delivers estrogen primarily to the affected tissues with minimal systemic absorption and can be highly effective.

🦴 Bone health

Systemic estrogen slows the bone loss associated with menopause and reduces fracture risk while it is being used.

That does not mean every woman should take estrogen solely to prevent osteoporosis. Bone-health decisions also depend on age, fracture risk, bone density, family history, medications, and other medical conditions.

“I Heard HRT Was Dangerous.”

This is probably the most important conversation to have.

For years, many women were understandably frightened of hormone therapy after early results from the Women’s Health Initiative (WHI) received enormous publicity.

The WHI provided extremely important information, but menopause medicine has become considerably more nuanced since then.

Today, major menopause guidelines emphasize that the risks and benefits of hormone therapy depend heavily on factors such as:

your age, how long it has been since menopause began, your medical history, which hormones are used, the dose, and how they are delivered.

The Menopause Society states that for most healthy women with bothersome menopause symptoms who are younger than 60 or within 10 years of menopause onset, the benefits of hormone therapy generally outweigh the risks.

That does not mean HRT is risk-free.

It means the question should be:

“What are the likely benefits and risks for this particular woman?”

Who May Be a Good Candidate?

A commonly favorable scenario is a healthy woman who:

  • Has bothersome hot flashes, night sweats, or other appropriate menopause symptoms
  • Is younger than 60 or within approximately 10 years of menopause onset
  • Does not have major contraindications
  • Understands the potential benefits and risks
  • Wants treatment after discussing her options

This is sometimes called the “timing hypothesis” or therapeutic window: starting hormone therapy closer to menopause generally has a more favorable benefit-risk profile than initiating systemic therapy for the first time many years later.

When Do We Become More Cautious?

Systemic hormone therapy is generally avoided or requires substantially more individualized evaluation in women with certain histories, including:

  • Breast or other estrogen-sensitive cancers
  • Previous blood clots
  • Previous stroke
  • Previous heart attack or established cardiovascular disease
  • Significant liver disease
  • Unexplained vaginal bleeding

Age and timing matter as well. Starting systemic hormone therapy for the first time after age 60 or more than 10 years after menopause generally carries greater absolute cardiovascular, clotting, and neurologic risks than starting earlier.

These situations do not mean that menopause symptoms simply have to be endured. They mean we may need a different treatment strategy.

Pills vs. Patches: Does It Matter?

Yes.

Oral estrogen travels through the liver before entering the general circulation. Transdermal estrogen, such as a patch, gel, or spray, is absorbed through the skin and avoids much of that first-pass liver effect.

Guidelines note that transdermal estrogen and lower doses may reduce the risk of blood clots and stroke compared with oral therapy, making route of administration an important part of individualized prescribing.

There is no universally “best” formulation for every woman.

What About “Bioidentical” Hormones?

This term causes enormous confusion.

Bioidentical does not automatically mean compounded.

There are FDA-approved forms of estradiol and micronized progesterone that are structurally identical to hormones produced by the human body.

Custom-compounded products are different.

ACOG recommends FDA-approved hormone products over routinely compounded “bioidentical” hormone therapy when approved options are available because compounded products have less regulatory oversight and may have greater variability in potency, purity, absorption, and quality.

The same caution applies to hormone pellets.

“Natural” is a marketing description, not a safety rating.

Do I Need a Giant Hormone Panel First?

Usually, no.

This surprises many people.

During perimenopause, hormone concentrations fluctuate significantly. A single estrogen or FSH measurement can therefore represent one moment in a constantly changing process.

ACOG specifically advises that routine hormone testing is generally not necessary before starting hormone therapy for typical menopausal symptoms.

For most women of typical menopausal age, diagnosis and treatment decisions are primarily based on:

symptoms + menstrual history + age + medical history + risk assessment.

Testing certainly has a role when the diagnosis is uncertain or another medical problem is suspected. But menopause treatment should not automatically become a monthly quest to “optimize” laboratory hormone numbers.

We treat the patient, not a hormone spreadsheet.

What If I Don’t Want Hormones?

That is completely reasonable.

Hormone therapy is an option, not an obligation.

Several evidence-based nonhormonal treatments can reduce hot flashes.

The Menopause Society’s evidence-based recommendations include certain:

  • SSRIs and SNRIs
  • Gabapentin
  • Fezolinetant (Veozah)
  • Oxybutynin in selected patients
  • Cognitive behavioral therapy
  • Clinical hypnosis

Weight loss may also improve vasomotor symptoms in some women with overweight or obesity.

Treatment can be matched to the individual. For example, a medication that also improves anxiety or depression may make sense for one person, while a nighttime medication may make more sense for someone whose biggest problem is disrupted sleep.

A newer nonhormonal option: fezolinetant

Fezolinetant (Veozah) works on temperature-regulating pathways in the brain rather than supplying estrogen.

It can be an option for moderate-to-severe hot flashes in women who cannot or prefer not to use hormones.

However, it is not risk-free. The FDA added a boxed warning after rare cases of serious liver injury were identified. Liver testing is required before treatment and periodically while taking the medication.

That is a good example of why “nonhormonal” does not automatically mean “safer.” Every medication deserves its own risk-benefit discussion.

What About Supplements?

This is another area where marketing tends to move faster than science.

Products such as black cohosh, soy extracts, herbal combinations, and numerous “menopause support” supplements are heavily marketed.

Unfortunately, evidence for many supplements is inconsistent, and supplement quality and ingredient concentrations can vary.

The Menopause Society’s 2023 evidence review did not recommend supplements or herbal remedies as evidence-based treatments for hot flashes.

That does not mean lifestyle is irrelevant.

Exercise, maintaining a healthy weight, limiting tobacco exposure, moderating alcohol, good sleep habits, adequate calcium and vitamin D intake, resistance training, and routine preventive healthcare remain extremely important during midlife.

They simply should not be marketed as guaranteed cures for vasomotor symptoms.

What About Vaginal Dryness If I Don’t Want Systemic HRT?

This deserves special attention because many women unnecessarily suffer with it.

Options include:

Nonhormonal

  • Vaginal moisturizers used regularly
  • Lubricants during sexual activity

Prescription options

  • Low-dose vaginal estrogen
  • Vaginal DHEA (prasterone)
  • Other selected therapies depending on symptoms and medical history

Low-dose vaginal estrogen is very different from taking systemic estrogen. Systemic absorption is minimal, and long-term treatment can be appropriate for many women.

For women with a history of estrogen-sensitive cancer, treatment should be individualized and coordinated with the appropriate clinicians.

What HRT Should Not Be Sold As

Hormone therapy is powerful medicine, but it is not a fountain of youth.

Current evidence does not support prescribing systemic estrogen simply to:

  • Prevent normal aging
  • Prevent dementia
  • Prevent cardiovascular disease
  • Cause weight loss
  • Fix every case of fatigue or brain fog
  • Treat arthritis
  • Improve skin or hair as the primary indication
  • “Optimize” hormones in an otherwise asymptomatic woman

Menopause is not a hormone-deficiency disease that every woman needs to have corrected.

For women experiencing natural menopause at the usual age, treatment is primarily about symptoms, quality of life, bone health when appropriate, and individualized risk.

One Important Exception: Early Menopause

Menopause occurring unusually early is a different clinical situation.

Women with primary ovarian insufficiency or premature/early menopause experience estrogen loss for considerably longer than someone entering menopause around the usual age.

That can affect bone and cardiovascular health.

Unless contraindicated, guidelines generally support hormone therapy in these women until approximately the average natural age of menopause.

So advice intended for a 52-year-old with natural menopause cannot automatically be applied to a 35-year-old with ovarian insufficiency.

How We Think About HRT

When a patient asks us about hormone therapy, we don’t begin with:

“Which hormone do you want?”

We begin with:

“What are we trying to improve?”

Then we work through several questions.

1. Are these symptoms actually consistent with menopause?

Sometimes another medical condition deserves evaluation first.

2. How much are the symptoms affecting your life?

Mild symptoms may not require medication. Symptoms that are destroying sleep, affecting work, relationships, sexual health, or quality of life deserve treatment.

3. What is your individual risk profile?

We consider age, timing of menopause, blood pressure, smoking, cardiovascular risk, clotting history, cancer history, liver disease, migraine history, uterine status, abnormal bleeding, medications, and other relevant factors.

4. Do you need systemic treatment at all?

Someone with severe hot flashes may benefit from systemic therapy.

Someone whose only problem is vaginal dryness may be better served by local treatment.

5. If hormones are appropriate, what is the most appropriate route and regimen?

The answer is individualized.

6. If hormones aren’t appropriate, or simply aren’t wanted, what evidence-based alternatives fit best?

There are legitimate options.

And finally:

7. Is the treatment actually helping?

Menopause care should not be “prescribe it and forget it.” Symptoms, side effects, health history, screening, and the continued need for treatment should be reassessed periodically.

There Is No Prize for Suffering Through Menopause

There is also no prize for taking hormones.

Some women feel dramatically better with hormone therapy. Others have mild symptoms and need nothing. Some prefer nonhormonal treatment. Others only need treatment for vaginal symptoms.

All of those can be reasonable outcomes.

Modern menopause care should not be driven by fear of hormones, but it also should not be driven by social-media promises that hormones will fix everything.

The best approach sits comfortably in the middle:

Identify the problem. Understand the evidence. Evaluate your individual risks. Review the alternatives. Then make the decision together.

If menopause symptoms are interfering with your sleep, work, relationships, sexual health, or quality of life, bring them up at your next visit. There are more evidence-based options available than many women realize.

This article provides general health education and is not a substitute for individualized medical advice. Hormone therapy and nonhormonal prescription treatments should be selected after reviewing your symptoms, medical history, medications, and individual risk factors.

References

American College of Obstetricians and Gynecologists. (n.d.). Hormone therapy for menopause. https://www.acog.org/womens-health/faqs/hormone-therapy-for-menopause

American College of Obstetricians and Gynecologists. (n.d.). Should I have hormone testing before starting hormone therapy? https://www.acog.org/womens-health/experts-and-stories/ask-acog/hormone-testing-before-hormone-therapy

American College of Obstetricians and Gynecologists. (2023). Compounded bioidentical menopausal hormone therapy: ACOG clinical consensus №6. https://www.acog.org/clinical/clinical-guidance/clinical-consensus/articles/2023/11/compounded-bioidentical-menopausal-hormone-therapy

The Menopause Society. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. https://menopause.org/wp-content/uploads/press-release/ht-position-statement-release.pdf

The Menopause Society. (2023). The 2023 nonhormone therapy position statement of The North American Menopause Society. https://www.menopause.org/docs/default-source/professional/2023-nonhormone-therapy-position-statement.pdf

The Menopause Society. (2024). The Menopause Society statement on misinformation surrounding hormone therapy. https://menopause.org/wp-content/uploads/2024/09/TMS-statement-on-HT-Misinformation.pdf

U.S. Food and Drug Administration. (2024). VEOZAH (fezolinetant) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216578s004lbl.pdf

U.S. Food and Drug Administration. (2024, September 12). FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause. https://www.fda.gov/drugs/drug-safety-communications/fda-adds-warning-about-rare-occurrence-serious-liver-injury-use-veozah-fezolinetant-hot-flashes-due

Want to talk it through?

Answer a few quick questions and we will match you to the right visit with Preston, then show you open times in Cape Girardeau. If you think you are having a medical emergency, call 911.

This article is for general education and does not replace a visit with your provider.

Originally published on Medium in November 2026.

Preston Holifield, DNP, APRN, FNP-C

Written by Preston Holifield, DNP, APRN, FNP-C

Preston is a nationally certified family nurse practitioner who leads Guardian Primary Care in Cape Girardeau, working alongside a Missouri Licensed Collaborating Physician. Meet our team.

Not Sure What Kind of Visit You Need?

Tell us what is going on and we will book the right visit with Preston at a time that works for you.

Guardian Primary Care, 2441 Myra Dr, Cape Girardeau, MO 63703. Visits are by appointment.